Vol 8: Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy.Report as inadecuate



 Vol 8: Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy.


Vol 8: Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 8: Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy.
This article is from Clinical Ophthalmology Auckland, N.Z., volume 8.AbstractBackground: The purpose of this study was to compare the effectiveness of pneumatic displacement combined with intravitreal bevacizumab IVB with that of pneumatic displacement PD alone to treat massive submacular hemorrhage SMH secondary to polypoidal choroidal vasculopathy PCV. Methods: Thirty-two eyes of 32 patients with massive SMH secondary to PCV were studied. Twenty-two eyes were treated with a combination of PD and 1.25 mg of intravitreal bevacizumab PD + IVB group, and ten eyes with pneumatic displacement alone PD group. Results: Pretreatment, the differences in best-corrected visual acuity and size of the SMH between the two groups were not significant P=0.59 and P=0.72, respectively. Complete displacement of the hemorrhage from under the fovea was achieved in 19 of 22 eyes 86.4% in the PD + IVB group and in five of ten eyes 50% in the PD group. The best-corrected visual acuity in the PD + IVB group was significantly better than that in the PD group at one, 3, and 6 months after treatment P



Author: Kitahashi, Masayasu; Baba, Takayuki; Sakurai, Madoka; Yokouchi, Hirotaka; Kubota-Taniai, Mariko; Mitamura, Yoshinori; Yamamoto, Shuichi

Source: https://archive.org/







Related documents